News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers
Prescription drug costs are a barrier to care for many patients, but especially so for the nine of 10 Medicare beneficiaries who report taking prescription drugs regularly. In fact, 14 percent of beneficiaries age 65 or older say they skip taking or sometimes do not even fill their prescriptions because of the expense.
How Medicare Says It Arrives At ‘Fair’ Prescription Drug Prices
When former President Biden signed the Inflation Reduction Act into law in 2022, he said that drug price negotiations and other provisions in the legislation would help lower costs for Medicare beneficiaries by bringing down the prices of certain medicines and capping out-of-pocket costs for many others. What remained hidden from view, however, is how the so-called maximum fair prices of the drugs selected for negotiation are determined. Now we have a glimpse behind the curtain. But it is only a peek.
Pharma is hopeful about Trump’s second term — here’s what to expect for drugmakers
Pharmaceutical companies appear to be hopeful about their growth under a Trump administration, after former President Joe Biden took a hardline stance on the industry for the last four years.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.